About Genomenon
Genomenon is an AI-driven genomics company whose mission is to save and improve lives by making genomic information actionable for patients with rare genetic diseases and cancer. Keeping pace with the ever-evolving body of knowledge within genomics, Genomenon connects current research with patient DNA to accelerate clinical decision making and pharmaceutical drug discovery.
For Rare Disease Day 2022, we will be creating a live-blog called, Our Rare Stories, with posts each day the week leading up to and on 2/28. We will be featuring rare disease organizations that we have partnered with, and customers such as Rady Children’s Hospital Institute for Genomic Medicine, along with highlighting our work with Pharma partners such as Inozyme.